Postdoc

Sapana's research is centered on investigating the intrinsic role of TAK1 kinase in regulating the immunosuppressive tumor microenvironment (TME) in pancreatic cancer. Her work aims to identify novel combination therapies that integrate TAK1 kinase inhibition with immunotherapy to enhance treatment efficacy for pancreatic cancer.

My research project mainly focuses on identifying adaptive mechanisms in Pancreatic ductal adenocarcinoma (PDAC) in response to KRAS-MAPK inhibitors and exploring potential combinatory drugs that synergize with KRAS-MAPK inhibitors.

 

 

 

 

​